- [PRESSWIRE] Vienna, Austria – 02.05.2003 — CEBINA GmbH, Central European Biotech Incubator and Accelerator, today announces the publication of the positive results of a Phase 2 clinical study that tested azelastine nasal spray as a new approach for reducing viral load in the nose of SARS-CoV-2 positive patients in the peer-reviewed journal Scientific Reports (1).
- [PRESSWIRE] Nairobi – November 9, 2022 — The Digital Innovations and Diagnostics for Infectious Diseases in Africa (Didida) had its official kick-off at the Strathmore University. Didida is an ambitious project to develop reliable, low-cost, mobile phone-connected tests to help detect multiple infectious diseases and non-communicable diseases (NCD) at once in sub-Saharan Africa. Didida also plans to invest in digital health infrastructure and train a new generation of African experts to meet the health needs of the continent.
- [PRESSWIRE] Nairobi – November 9, 2022 — The Digital Innovations and Diagnostics for Infectious Diseases in Africa (Didida) had its official kick-off at the Strathmore University. Didida is an ambitious project to develop reliable, low-cost, mobile phone-connected tests to help detect multiple infectious diseases and non-communicable diseases (NCD) at once in sub-Saharan Africa. Didida also plans to invest in digital health infrastructure and train a new generation of African experts to meet the health needs of the continent.
- [PRESSWIRE] London, UK – 30.09.22 — COPTRZ Ltd, have launched their new drone learning experience platform (LXP) platform COPTRZ ACADEMY. COPTRZ claim that this is the leading platform of its type anywhere in the World.
- [PRESSWIRE] London, UK – 30.09.22 — COPTRZ Ltd, have launched their new drone learning experience platform (LXP) platform COPTRZ ACADEMY. COPTRZ claim that this is the leading platform of its type anywhere in the World.
- [PRESSWIRE] Austria – 04.07.22 — CEBINA GmbH, Central European Biotech Incubator and Accelerator, today announces the publication of research results demonstrating that the commonly used anti-histamine, azelastine, is a potent inhibitor of major variants of SARS- CoV-2 in the peer-reviewed journal Frontiers in Pharmacology (1).
- [PRESSWIRE] LUBBOCK, TX — April 19, 2022 – NemaLife Inc., a DEA-registered and innovation-driven techbio company, has partnered with the research group led by Professor David E. Olson at the University of California, Davis to characterize the in vivo effects of several of their novel psychoplastogens.
- [PRESSWIRE] Vienna – 23rd February 2022 — Eveliqure Biotechnologies GmbH, a clinical stage biotechnology company, today announces the publication of positive Phase I data with ShigETEC, its vaccine candidate against Shigellae and enterotoxic E. coli in the peer-reviewed journal Vaccines (https://doi.org/10.3390/vaccines10020340).
- [PRESSWIRE] Austria – 10.12.21 — CEBINA GmbH, Central European Biotech Incubator and Accelerator, today informs about the potential of the antihistamine drug azelastine hydrochloride to be an effective anti-viral approach against major respiratory viruses, such as SARS-CoV-2 and its variants, influenza and Respiratory Syncytial Virus (RSV).
- Red Devil, Jan Vertonghen co-invests in Ghent-based scale-up to expand groundbreaking epilepsy AI technology to sleep and other neurological disorders…
- [PRESSWIRE] Austria – 04 May, 2021 — CEBINA GmbH, an Austrian biotech company, today announces that azelastine, previously identified as a potential anti-COVID-19 drug, is equally potent against newly emerging dominant variants of SARS-CoV-2 compared to the original virus. Azelastine is available as an anti-allergy nasal spray and is currently being tested in a Phase 2 efficacy trial for the treatment of early-stage COVID-19 disease.
- [PRESSWIRE] SANTA ANA, January 26, 2021 — Airionex, the leading global provider of bi-polar ionization air and surface purification technology, announced today that it has hired Françoise Parker as Senior Vice President of Sales and Marketing. Françoise will report to CEO Jukka Matikka, and will be responsible for sales team leadership, accelerating Airionex revenue throughout North America, the development and management of key channels, and overseeing the company’s marketing strategy.
- [PRESSWIRE] Austria – 19.11.20 — Eveliqure Biotechnologies GmbH, a clinical-stage biotechnology company, today announces the publication of preclinical data with ShigETEC, its vaccine candidate against Shigellae and Enterotoxic E. coli in the peer-reviewed journal Vaccines (https://doi.org/10.3390/vaccines8040689).
- [PRESSWIRE] CA, US – 18 September, 2020 — Airionex announced today the results of new independent testing. Varionix® active bipolar ionization air cleaning technology from Airionex has been verified to be effective for disinfecting coronavirus from the air. The virus was completely eliminated within minutes.
- [PRESSWIRE] Vienna – 30th June 2020 — Eveliqure Biotechnologies today announces that further financing has been secured from Arax Capital Partners comprising the last instalment of a €1.7M total investment provided by Arax. This is complemented by further private investment from Baobá and a Swiss based family office, and totals around €0.5M.
- [PRESSWIRE] Vienna – 4 June, 2020 — The Austrian biotech company CEBINA GmbH announces that it has received seed funding for its extended spectrum Coronavirus vaccine project, which is part of CEBINA’s broad-scale efforts offering short-, mid- and longer-term solutions to fight the COVID-19 pandemic. This seed funding will support proof-of-concept studies of the vaccine that will allow progress to pre-clinical development, scheduled for Q1/2021. The funds are provided by the Blom Family Office.
- [PRESSWIRE] Luxembourg – 14 May, 2020 — The pandemic has taken the medical world by surprise and challenged the medical device industry, putting a heavy strain on manufacturers. How does a CEO juggle between the intensifying demand for reliable medical equipment, the need for innovations, and the safety of his employees to make sure that COVID-19 is behind us in the shortest time possible?
- [PRESSWIRE] Austria – 20 April, 2020 — Austrian biotech company Calyxha Biotechnologies GmbH is pleased to announce the grant of European Patent No. EP3383381. This patent covers the use of calixarene compounds for neurodegenerative diseases, including Parkinson’s disease. It represents the company’s first granted patent, with prosecution of the corresponding patent applications ongoing in other territories.
- [PRESSWIRE] HELSINKI – 16 April, 2020 — Karsa Oy, Entwickler und Hersteller von chemischen Bedrohungsdetektoren für Sicherheitsanwendungen, hat in der Bundesrepublik Deutschland ein neues Unternehmen, Karsa Oy (Deutschland), gegründet. Die innovative chemischen Ionisations-Massenspektrometrie-Technologie wurde ursprünglich für die Erforschung des Klimawandels entwickelt und zuerst für den Nachweis von Explosivstoffen in Luftfracht angepasst.
- [PRESSWIRE] AUSTIN, TEXAS – March 9, 2020: Electroninks, the world’s most advanced supplier of particle-free silver, gold, and platinum conductive inks and pastes, today announces that it is entering into a strategic alliance with Enjet Inc., the world leader in ultra-high resolution printing to support advanced manufacturing of display, touchpanel, and packaging products. The key to this engagement is the shared value of commitment to customer success. Combining capabilities and resources will demonstrate both company’s continued investment in delivering world class conductive ink and printing equipment products.
- [PRESSWIRE] London, UK. 09 September, 2019. The 2019 Aircraft Cabin Air Conference (aircraftcabinair.com) will be the largest conference ever to take place in relation to the air you breathe on aircraft and is being held on 17-18 September 2019 in London.
- [PRESSWIRE] LONDON, July 29, 2019 — In 2018, the urology devices market is estimated at $6.9bn and is expected to grow at a CAGR of 6.1% from 2018 to 2029. The urinary incontinence market dominated the market in 2018 and accounted for 33.8% of the urology devices market.
- [PRESSWIRE] London, United Kingdom – 20 May, 2019 — In the largest independent study into the driving forces behind staff retention in England, 40% of academy staff — and 46% of teachers — said that they have considered resigning from their current post in the past three months.
- [PRESSWIRE] Boston, MA – June 12, 2018 — Zaluvida a global life science group, announced today the formation of a Scientific Advisory Board (SAB) to inform the Human Health Research & Development department about the latest research, scientific methods, and opportunities for weight-loss management, and help further technology and product development for the company.
- [PRESSWIRE] Los Angeles – 29.12.2015 — To find out where Americans want to make improvements in their lives in 2016, leading personal finance website GOBankingRates.com surveyed over 5,000 people on their New Year’s resolutions for the upcoming year.
- [PRESSWIRE] Minneapolis – 29.12.2015 — The numbers are in: Sleep Number customers who adjust the firmness of their bed — their Sleep Number® setting — are 58 percent more likely to have improved sleep quality.
